Drugs / Rosuvastatin 20mg
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT06105060 Comparator | Dec 2023 → Jun 2024 | metabolic dysfunction-associated steatohepatitis | Beni-Suef University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rosuvastatin 20mg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06105060 ↗ |
| Known as | NAC | “The present study evaluated the efficacy of N-acetyl cysteine (NAC) and rosuvastatin (RSV) compared with conventional vitamin E in patients with NASH.” PMID 40480879 ↗ Jun 2025 |